Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
33.53
-0.90 (-2.61%)
Aug 11, 2025, 2:07 PM - Market open
Paramount Global Employees
Harrow had 382 employees as of December 31, 2024. The number of employees increased by 67 or 21.27% compared to the previous year.
Employees
382
Change (1Y)
67
Growth (1Y)
21.27%
Revenue / Employee
$557,220
Profits / Employee
-$56,796
Market Cap
1.23B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 382 | 67 | 21.27% |
| Dec 31, 2023 | 315 | 98 | 45.16% |
| Dec 31, 2022 | 217 | 35 | 19.23% |
| Dec 31, 2021 | 182 | 57 | 45.60% |
| Dec 31, 2020 | 125 | -8 | -6.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HROW News
- 5 days ago - Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference - GlobeNewsWire
- 13 days ago - Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 - GlobeNewsWire
- 25 days ago - Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States - Business Wire
- 25 days ago - Samsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United States - Business Wire
- 27 days ago - HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 4 weeks ago - Harrow's Internal $100 Price Target Is Ambitious, But New Bloomberg Data Backs It Up - Seeking Alpha
- 4 weeks ago - Harrow: Immense Upside Potential - Seeking Alpha
- 7 weeks ago - Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications - Business Wire